《CELL,4月8日,The architecture of SARS-CoV-2 transcriptome》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-04-09
  • The architecture of SARS-CoV-2 transcriptome

    Authors

    Dongwan Kim1,2, Joo-Yeon Lee3

    , Jeong-Sun Yang3

    , Jun Won Kim3

    , V. Narry Kim1,2,4,*, and

    Hyeshik Chang1,2,*

    DOI: 10.1016/j.cell.2020.04.011

    SARS-CoV-2 is a betacoronavirus responsible for the COVID-19 pandemic. Although the

    SARS-CoV-2 genome was reported recently, its transcriptomic architecture is unknown.

    Utilizing two complementary sequencing techniques, we here present a high-resolution map

    of the SARS-CoV-2 transcriptome and epitranscriptome. DNA nanoball sequencing shows

    that the transcriptome is highly complex owing to numerous discontinuous transcription

    events. In addition to the canonical genomic and 9 subgenomic RNAs, SARS-CoV-2

    produces transcripts encoding unknown ORFs with fusion, deletion, and/or frameshift. Using

    nanopore direct RNA sequencing, we further find at least 41 RNA modification sites on viral

    transcripts, with the most frequent motif, AAGAA. Modified RNAs have shorter poly(A) tails

    than unmodified RNAs, suggesting a link between the modification and the 3′ tail. Functional

    investigation of the unknown transcripts and RNA modifications discovered in this study will

    open new directions to our understanding of the life cycle and pathogenicity of SARS-CoV-2.

  • 原文来源:https://www.cell.com/pb-assets/products/coronavirus/CELL_CELL-D-20-00765.pdf
相关报告
  • 《Cell,4月29日,Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-05-03
    • The coronavirus disease 2019 (COVID-19) pandemic, caused by the SARS-CoV-2 virus, has highlighted the need for antiviral approaches that can target emerging viruses with no effective vaccines or pharmaceuticals. Here, we demonstrate a CRISPR-Cas13-based strategy, PAC-MAN (prophylactic antiviral CRISPR in human cells), for viral inhibition that can effectively degrade RNA from SARS-CoV-2 sequences and live influenza A virus (IAV) in human lung epithelial cells. We designed and screened CRISPR RNAs (crRNAs) targeting conserved viral regions and identified functional crRNAs targeting SARS-CoV-2. This approach effectively reduced H1N1 IAV load in respiratory epithelial cells. Our bioinformatic analysis showed that a group of only six crRNAs can target more than 90% of all coronaviruses. With the development of a safe and effective system for respiratory tract delivery, PAC-MAN has the potential to become an important pan-coronavirus inhibition strategy.
  • 《BioRxiv,3月14日,The architecture of SARS-CoV-2 transcriptome》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-15
    • The architecture of SARS-CoV-2 transcriptome Dongwan Kim, Joo-Yeon Lee, Jeong-Sun Yang, Jun Won Kim, V. Narry Kim, Hyeshik Chang doi: https://doi.org/10.1101/2020.03.12.988865 Abstract SARS-CoV-2 is a betacoronavirus that is responsible for the COVID-19 pandemic. The genome of SARS-CoV-2 was reported recently, but its transcriptomic architecture is unknown. Utilizing two complementary sequencing techniques, we here present a high-resolution map of the SARS-CoV-2 transcriptome and epitranscriptome. DNA nanoball sequencing shows that the transcriptome is highly complex owing to numerous recombination events, both canonical and noncanonical. In addition to the genomic RNA and subgenomic RNAs common in all coronaviruses, SARS-CoV-2 produces a large number of transcripts encoding unknown ORFs with fusion, deletion, and/or frameshift. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.